Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03267186
Title Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant
Recruitment Active, not recruiting
Gender
Phase Phase II
Variant Requirements No
Sponsors Andrew Rezvani
Indications

acute leukemia

acute lymphoblastic leukemia

acute myeloid leukemia

chronic myeloid leukemia

Therapies

Ibrutinib

Age Groups:
Covered Countries USA


No variant requirements are available.